About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, June 3rd, 2015

The QualityStocks
Daily Stock List


Direct Insite Corp. (DIRI)

RedChip, Zacks, Wall Street Resources, FeedBlitz, and SmallCapVoice reported on Direct Insite Corp. (DIRI), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Direct Insite Corp. provides a strong platform for unified working capital management, which facilitates greater than $160 billion worth of transactions each year between more than 375,000 companies globally. The Company is the provider of the PAYBOX™ integrated receivables platform. PAYBOX™ is chiefly sold through banks to corporate users of their treasury management and lockbox services. OTCQB-listed, Direct Insite is headquartered in Fort Lauderdale, Florida.

The Company’s PAYBOX™ is an integrated receivables solution, which combines electronic invoicing, online approvals and adjustments, electronic payments, and integration with any legacy accounting, ERP or lockbox system. PAYBOX™ is used by banks and corporations to reduce Days Sales Outstanding, lower costs, and improve straight-through accounts receivable (AR) posting.

Direct Insite’s AR Solutions include PAYBOX™ for Corporates and PAYBOX™ for Banks. The Company provides a range of consulting, implementation, support and educational services to help ensure the success of an organization’s accounts payable (AP), accounts receivable and payments automation projects. In addition, Direct Insite offers best-in-class supplier on-boarding services proven to increase e-invoicing adoption.

Services that Direct Insite provides include business case support, business process and technology review, business process re-engineering, workflow management, automation best practices, and deployment strategies. The Company also provides project management support, comprehensive staff training, administrator training, supplier on-boarding services, and expert support.

In May, Direct Insite announced financial results for Q1 2015. Net income for the three months ended March 31, 2015 was $80,000, versus a net loss of $86,000 for the quarter ended March 31, 2014. The year-over-year gain in quarterly net income was because of higher recurring revenue and lower expenses in 2015.

Revenue for the three months ended March 31, 2015 was $2,060,000. This represents an increase of $90,000, or 4.6 percent, from revenue of $1,970,000 for the three months ended March 31, 2014.

Recurring revenue for the first quarter was $1,707,000, an increase of $89,000, or 5.5 percent, from recurring revenue of $1,618,000 for the comparable year ago period. The year-over-year increase was because of the November 2014 launch of the PAYBOX™ integrated receivables solution and increased usage from certain other customers.

Direct Insite Corp. (DIRI), closed Wednesday's trading session at $1.17, up 17.00%, on 40,308 volume with 55 trades. The average volume for the last 60 days is 13,953 and the stock's 52-week low/high is $0.442/$1.01.

BioSig Technologies, Inc. (BSGM)

Pumps and Dumps, Stockgoodies, SizzlingStockPicks, WallstreetSurfers, PennyStock Tweets, and SECFilings.com News reported on BioSig Technologies, Inc. (BSGM), and we also report on the Company, here at the QualityStocks Daily Newsletter.

BioSig Technologies, Inc. is a medical device company headquartered in Minneapolis, Minnesota. It is developing PURE EP™, which is a proprietary technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures. The Company’s intention is to seek Food and Drug Administration (FDA) 510(k) approval for the PURE EP™ System. BioSig is preparing to commercialize the PURE EP™ System.

BioSig Technologies’ shares trade on the OTC Markets Group’s OTCQB. The Company maintains an office in Los Angeles, California devoted to research and development (R&D).

The Company’s PURE EP™ is a next-generation surface electrocardiogram and intracardiac multichannel recording and analysis system. The design of it is to assist electrophysiologists in making clinical decisions in real-time through acquiring and displaying high-fidelity cardiac signal recordings and providing guidance in identifying ablation targets (areas of tissue to destroy that otherwise create a heart rhythm disturbance or arrhythmia).

BioSig Technologies has achieved proof of concept validation via UCLA EP & Animal Labs. It is collaborating with several of the nation's most prestigious cardiac arrhythmia centers. These include Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, and the Mayo Clinic.

Recently, BioSig Technologies announced that Michele Chin-Purcell, Ph.D., would be joining the Company as Vice President, Quality and Regulatory Affairs. Dr. Chin-Purcell has more than twenty years of experience in Research, Quality, and Regulatory Affairs in the life sciences. Most recently, Dr. Chin-Purcell served as Senior Director, Regulatory Affairs at Spinal Modulation in Menlo Park, California.

Last week, BioSig Technologies announced that it appointed Mr. David Weild to the Board of Directors, effective immediately. Mr. Weild has been elected to Chair the Audit Committee of the Board as BioSig prepares to uplist to a National Stock Exchange. Mr. Weild brings wide-ranging financial, economic, stock exchange, capital markets, and small company expertise to BioSig Technologies achieved through his successful career on Wall Street.

BioSig Technologies, Inc. (BSGM), closed Wednesday's trading session at $2.70, up 13.45%, on 23,500 volume with 52 trades. The average volume for the last 60 days is 22,061 and the stock's 52-week low/high is $1.31/$4.80.

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires and PennyStocks Forever reported on Cocrystal Pharma, Inc. (COCP), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. is a biotechnology company developing novel antiviral therapeutics for human diseases. It merged in 2014 with Biozone Pharmaceuticals, Inc. Cocrystal Pharma announced in November of 2014 the closing of its merger with RFS Pharma, LLC. RFS Pharma is a privately owned biotechnology company founded by renowned drug developer, Dr. Raymond Schinazi. Cocrystal Pharma lists on the OTC Bulletin Board. The Company has its headquarters in Bothell, Washington.

Cocrystal Pharma focuses on the discovery and development of novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. It employs innovative technologies and Nobel Prize winning expertise to create first- and best-in-class antivirals. The design of these technologies and its market-focused approach to drug discovery are to efficiently deliver small molecule therapeutics that are safe, effective, and convenient to administer. 

Cocrystal Pharma has earlier received strategic investments from Teva Pharmaceuticals, OPKO Health (OPK), and The Frost Group. OPKO Health and The Frost Group together own approximately 48 percent of Cocrystal Pharma. Cocrystal Pharma has five therapeutic programs targeting the Hepatitis C Virus (HCV), Influenza Virus, Dengue Virus, the Norovirus, and others. It has identified a picomolar inhibitor of NS5a, another essential viral replication protein.

The Company is targeting two Hepatitis C replication enzymes with its Polymerase program at lead optimization stage and its Helicase program at lead identification stage. Its Influenza, Dengue, and Norovirus programs are targeting unmet multi-billion dollar market opportunities with first-in-class antivirals. Cocrystal has developed what it believes to be the first high-throughput screening technology for inhibitors of a key essential Ebola virus gene product. It utilized its core platform technology to develop the in vitro test.

Cocrystal Pharma is developing drug candidates specifically designed to be effective against all strains of the influenza virus and to have a high barrier to resistance. Selection of a lead compound for clinical development is planned to take place this year. Regulatory filings to begin clinical studies for influenza are planned for December 2015.

Cocrystal Pharma’s Hepatitis C program continued to make progress in Q2 of 2014. It has chosen CDI-244 for development as a treatment for patients with Hepatitis C (HCV). Cocrystal plans regulatory filings to start clinical trials of CDI-244 this year. Company scientists have made first-rate progress discovering potent inhibitors of the influenza endonuclease, an enzyme that is essential for viral genome replication.

Cocrystal Pharma will be presenting at the Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 from 12:30 p.m. to 1:00 p.m. at the Grand Hyatt in New York City. Dr. Raymond F. Schinazi, Chairman of the Board of Directors and Mr. Jeffrey Meckler, Interim Chief Executive Officer will be presenting on behalf of Cocrystal Pharma.

Cocrystal Pharma, Inc. (COCP), closed Wednesday's trading session at $1.36, up 5.43%, on 2,219,320 volume with 1,053 trades. The average volume for the last 60 days is 790,095 and the stock's 52-week low/high is $0.252/$1.53.

VG Life Sciences, Inc. (VGLS)

NYSE Post, The Bull Report, Wall Street Wolves, and PennyStocks24 reported recently on VG Life Sciences, Inc. (VGLS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

VG Life Sciences, Inc. concentrates on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. An OTCQB-listed biotechnology company, it is researching two core technologies. One is Targeted Peptide Technology, or TPT, which is now its principal focus. The other is Metabolic Disruption Technology, or MDT, which is its secondary focus. VG Life Sciences is based in Santa Barbara, California. 

The Company controls greater than 40 US and international patents and pending patents protecting its exclusive biotechnology platform technologies. Its R&D programs are based on technology, which Dr. M. Karen Newell Rogers developed while working at the University of Colorado, the University of Vermont, and Texas A&M University. VG holds the exclusive license to this technology.

VG Life Sciences has collaborated with many scientists and clinicians at universities across the nation. This includes Stanford University, Harvard University, and the Scott & White Healthcare Center, where VG tests TPT in inflammatory disease applications in which it believes TPT could have a benefit.

The Company has completed its Phase I clinical trial conducted at the Cancer Therapy & Research Center at the University of Texas Health Sciences Center at San Antonio. This involves patients with solid tumors. It examines the safety and efficacy of hydroxychloroquine (HCQ) in combination with sorafenib (marketed as Nexavar®) co-developed by Bayer AG and Onyx Pharmaceuticals. VG Life Sciences holds the use patent (applied for) for this combination treatment.

VG Life Sciences contracted ITR Canada, Inc. in October 2013 to conduct IND-enabling animal safety studies with its patented peptide VG1177. VG now expects these studies to conclude this year. These animal safety studies are the next important step to move toward clinical trials.

VG Life Sciences’ goals for 2015 include completing the Animal Safety Studies expeditiously, beginning a Phase I clinical trial with VG1177, expanding its cancer clinical trial at the University of Texas, and entering meaningful discussions with biopharma companies regarding collaborations using its technologies.

This past January, VG Life Sciences announced the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent. The patent, along with VG’s existing intellectual property (IP), demonstrates its expertise in researching the role of CLIP (class II-associated invariant chain peptide) in chronic inflammatory conditions. This past March, VG Life Sciences announced that the USPTO issued an important new composition of matter patent covering methods for modulating immune system function through the targeting of CLIP.

VG Life Sciences, Inc. (VGLS), closed Wednesday's trading session at $0.07, up 12.90%, on 194,491 volume with 22 trades. The average volume for the last 60 days is 60,541 and the stock's 52-week low/high is $0.0425/$0.189.

Premier Holding Corp. (PRHL)

TopPennyStockMovers and Pumps and Dumps reported on Premier Holding Corp. (PRHL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Premier Holding Corp. is an energy holding company focusing on acquiring and integrating energy companies as synergistic subsidiaries. Premier accumulates residential and commercial clients in deregulated markets from all subsidiaries and cross sells energy and energy efficiency products and services, maximizing profit potential and minimizing cost of client procurement. The Company is headquartered in Tustin, California and its shares trade on the OTCQB.

Premier Holding, by way of its subsidiaries, offers renewable energy production, energy efficiency products and services to commercial middle-market companies, Fortune 500 brands, developers and management companies of large-scale residential developments. Its companies lower its clients’ price and usage of energy. Its subsidiary, The Power Company (TPC), through deregulated energy expertise, has helped tens of thousands of clients.

Through its energy efficiency company, E3 - Energy Efficiency Experts, Premier allows for ongoing support via energy management and information systems. Premier Holding’s additional integrated business offerings include direct energy services as Power Purchase Agreements (PPAs), energy financing and leasing of generation programs in urban and rural real estate environments, lighting efficiency systems, and refrigeration systems.

The Company continues to explore opportunities to become a supplier through application or acquisition/merger with an existing supplier to fulfill its plans for growth. Once completed, the new subsidiary will be a power provider/supplier licensed with the Public Utility Commissions. This subsidiary will enable Premier to leverage the marketing success of energy brokers such as The Power Company and ultimately create new energy efficiency prospects for E3, enabling Premier to further its plan of integration in this sector.

Premier Holding has acquired 85 percent of Lexington Power and Light, LLC (LP&L) and operates now as a supplier of energy (electricity and natural gas) in deregulated markets. This purchase of Lexington Power and Light is an important part of Premier’s larger plan to provide "everything energy" to its thousands of clients and the huge potential energy market.

Today, Premier Holding announced that its subsidiary, The Power Company (TPC), successfully negotiated an agreement between one of its outstanding suppliers and the Township of Niles, Illinois, situated just northwest of Chicago. The Power Company's (TPC) strategic partnership team is helping Niles Township, providing power at a very competitive rate for the next two years. Patrick Farah, managing member at TPC, stated, "We are extremely proud of what we were able to accomplish for Niles. They had a number of choices and TPC was able to provide them the best option for their particular needs.”

Premier Holding Corp. (PRHL), closed Wednesday's trading session at $0.07, up 12.72%, on 32,600 volume with 6 trades. The average volume for the last 60 days is 54,721 and the stock's 52-week low/high is $0.022/$0.1225.


The QualityStocks
Company Corner


Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0076, up 52.00%, on 7,768,109 volume with 246 trades. The stock’s average daily volume over the past 60 days is 13,272 and its 52-week low/high is $0.0035/$0.45.

Dominovas Energy Corp. was pleased to announce the launch of its new, redeveloped website (http://dominovasenergy.com). In addition to a clean, fresh look and user-friendly navigation, the new site comes complete with additional company details and real-time news and financial reporting. The site has been designed to meet all relevant accessibility standards, making it accessible through a wider range of web browsers and mobile devices, including smart phones and tablets. 

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Set for Relaunch With New Branding

Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview

Dominovas Energy Corp. Appoints International Business Professional to Board of Directors

Pure Hospitality Solutions, Inc. (PNOW)

The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0022, off by 8.33%, on 11,532,754 volume with 45 trades. The stock’s average daily volume over the past 60 days is 2,360,521, and its 52-week low/high is $0.0013/$0.5882.

Pure Hospitality Solutions, Inc. announced today, that the Company has completed their first quarter filings with the OTC Markets. Pure Hospitality Solutions files first quarter disclosures to not only remain current with OTC Markets, but to remain as transparent as the Pink Sheets market allows. "This was a very important filing for us," stated Melvin Pereira, President and CEO of Pure Hospitality Solutions, Inc. "Why?  Because this is the filing where the Company actually begins to make sense. If you haven't read the first quarter disclosures yet, we certainly encourage you to. We believe, you will truly walk away with a better picture of what we once were, where we are today, and what true value the upcoming months hold for Pure."

Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Pure has four objectives:

1.   To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2.   Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3.   Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4.   Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Pure Hospitality Solutions, Inc. Company Blog

Pure Hospitality Solutions, Inc. News:

Pure Hospitality Solutions Files First Quarter Disclosures

PURE Hospitality Solutions Nears Completion of First Quarter Filings

Pure Hospitality Solutions Teams up with Investors Hangout

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.075, on 287,501 volume with 21 trades. The stock’s average daily volume over the past 60 days is 41,264, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. announced today that its subsidiary, ReadyOp Communications, Inc., has begun work on a project with a major retail corporation based in Arkansas. The project, in partnership with two private companies, is expected to continue for the next three years. Specific terms and financial information for the project could not be released. The ReadyOp™ platform will be used for planning, monitoring and reporting the work being done for each individual store location.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic, Inc. (CLRI) Begins Nationwide Retail Store Project

Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement with Houston-Galveston Area Council

Cleartronic, Inc. (CLRI) on the "Your Monies Worth" Show

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.07, up 40.00%, on 66,050 volume with 9 trades. The stock’s average daily volume over the past 60 days is 32,604, and its 52-week low/high is $0.042/$0.42.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International

Mobile Lads Begins Operating North American Shopping Network Simbadeals.com

Mobile Lads Purchases Majority of North American Shopping Network From Domark International

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0015, up 25.00%, on 2,391,800 volume with 20 trades. The stock’s average daily volume over the past 60 days is 4,819,693, and its 52-week low/high is $0.001/$0.154.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251